HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gabriela Hobbs Selected Research
Gabriela Hobbs Research Topics
Disease
10
Neoplasms (Cancer)
01/2024 - 01/2017
7
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 01/2017
6
Leukemia
10/2023 - 10/2019
5
Primary Myelofibrosis (Myelosclerosis)
03/2024 - 07/2020
4
Polycythemia Vera
01/2024 - 07/2020
4
Essential Thrombocythemia
01/2024 - 07/2020
2
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2023 - 01/2018
2
Infections
11/2020 - 06/2016
1
Splenomegaly
03/2024
1
Mental Disorders (Mental Disorder)
10/2023
1
Sleep Initiation and Maintenance Disorders (Insomnia)
10/2023
1
Cardiovascular Diseases (Cardiovascular Disease)
06/2022
1
Inflammation (Inflammations)
06/2022
1
Hematologic Neoplasms (Hematological Malignancy)
06/2022
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1
Acute Kidney Injury (Acute Renal Failure)
01/2020
1
Eosinophilia
01/2020
1
Febrile Neutropenia
01/2020
1
Anemia
01/2020
1
Thrombocytopenia (Thrombopenia)
01/2020
1
Systemic Mastocytosis
12/2018
1
Fatigue
01/2018
1
Nausea
01/2018
1
Mucositis
01/2017
1
Cytopenia
01/2017
1
Fever (Fevers)
06/2016
1
Colitis
08/2013
Drug/Important Bio-Agent (IBA)
4
Interferons
IBA
01/2024 - 07/2020
3
ruxolitinib
IBA
03/2024 - 01/2020
3
Tyrosine Kinase Inhibitors
IBA
10/2023 - 01/2018
2
Cytokines
IBA
01/2024 - 01/2022
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2020 - 01/2018
1
parsaclisib
IBA
03/2024
1
Dasatinib (BMS 354825)
FDA Link
10/2023
1
Venlafaxine Hydrochloride (Effexor)
FDA Link
Generic
10/2023
1
Transforming Growth Factor beta (TGF-beta)
IBA
06/2022
1
Phosphotransferases (Kinase)
IBA
06/2022
1
Calreticulin
IBA
06/2022
1
Janus Kinase 2
IBA
06/2022
1
Proteins (Proteins, Gene)
FDA Link
06/2022
1
Protein-Lysine 6-Oxidase (Lysyl Oxidase)
IBA
06/2022
1
ixazomib
IBA
01/2022
1
Proteasome Inhibitors
IBA
01/2022
1
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
01/2022
1
pembrolizumab
IBA
12/2021
1
asciminib
IBA
12/2021
1
venetoclax
IBA
12/2021
1
Pioglitazone (Actos)
FDA Link
12/2021
1
Immune Checkpoint Inhibitors
IBA
12/2021
1
Fluconazole (Zonal)
FDA Link
Generic
11/2020
1
Interferon-alpha (Interferon Alfa)
IBA
07/2020
1
Brentuximab Vedotin
IBA
01/2020
1
Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
IBA
01/2020
1
Immunoconjugates (Immunoconjugate)
IBA
01/2020
1
Lenalidomide (CC 5013)
FDA Link
10/2018
1
cabozantinib
IBA
01/2018
1
Electrolytes
IBA
01/2018
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2018
1
fms-Like Tyrosine Kinase 3
IBA
01/2018
1
MLN 8237
IBA
01/2017
1
Aurora Kinase A
IBA
01/2017
1
DNA (Deoxyribonucleic Acid)
IBA
08/2013
1
Paraffin
IBA
08/2013
Therapy/Procedure
10
Therapeutics
10/2023 - 01/2017
7
Drug Therapy (Chemotherapy)
01/2023 - 06/2016
2
Induction Chemotherapy
01/2020 - 01/2017
1
Cell Transplantation
12/2020
1
Transplantation
06/2016
1
Hematopoietic Stem Cell Transplantation
08/2013